Human Chorionic Gonadotropin (hCG)
Endogenous Glycoprotein Hormone / FDA-approved prescription biologic (indication-specific)
Human chorionic gonadotropin is a placental glycoprotein hormone and prescription biologic that acts as an LH receptor agonist, used in indication-specific fertility and gonadal function protocols.
For research use only.
Key Facts
- CAS
- โ
- Molecular Weight (MW)
- Variable glycoprotein; approximately 36.7 to 38 kDa depending on glycosylation/source
- Half-life
- ~24-36 hours biological half life (route and product dependent)
- Unit
- IU
- Administration Route
- Intramuscular; some products/routes vary by labeling and clinical context
- Frequency
- Protocol dependent
- Last updated
- 3/10/2026
- Targets
- LH/CG receptor
Overview
Human chorionic gonadotropin is a placental glycoprotein hormone and prescription biologic that acts as an LH receptor agonist, used in indication-specific fertility and gonadal function protocols.
Protocol
- Dosage Range
- Common labeled doses range from 500 to 10000 USP units depending on indication
- Frequency
- Protocol dependent
- Cycle
- Use only per FDA labeling / prescriber direction
- Administration Route
- Intramuscular; some products/routes vary by labeling and clinical context
- Reconstitution Guide
- Reconstitute only per product labeling with supplied diluent; store as directed after reconstitution
Science
Mechanism of Action
Acts as an LH receptor agonist to stimulate testicular testosterone production in males and trigger final follicular maturation/ovulation in female fertility protocols.
Targets
LH/CG receptor
Studies
- โ Journal/year not available
- โ Journal/year not available
- โ Journal/year not available
Benefits
Supports testosterone production in appropriate male medical contextsUsed in selected cases of hypogonadotropic hypogonadismUsed in fertility protocols for ovulation triggeringUsed in selected pediatric cryptorchidism protocols
Potential Side Effects
- Injection site reactions
- Headache
- Mood changes
- Gynecomastia
- Fluid retention
- Acne
- Risk of ovarian hyperstimulation syndrome in female fertility use
References
- FDA Pregnyl labelExternal link ยท Year โ
- DailyMed PregnylExternal link ยท Year โ
- DailyMed Chorionic Gonadotropin for InjectionExternal link ยท Year โ
- WADA Prohibited ListExternal link ยท Year โ